| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Jan―13 |
Dysregulated autoantibodies targeting AGTR1 are associated with the accumulation of COVID-19 symptoms |
Dennyson Leandro M. Fonseca, Maj Jäpel, Michael Adu Gyamfi, Igor Salerno Filgueiras, Gabriela Crispim Baiochi, Yuri Ostrinski, Gilad Halpert, Yael Bublil Lavi, Elroy Vojdani, Thayna Silva-Sousa, Júlia Nakanishi Usuda, Juan Carlo Santos e Silva, Paula P. Freire, Adriel Leal Nóbile, Anny Silva Adri, Pedro Marçal Barcelos, Yohan Lucas Gonçalves Corrêa, Fernando Yuri Nery do Vale, Letícia Oliveira Lopes, Solveig Lea Schmidt, Xiaoqing Wang, Carl Vahldieck, Benedikt Fels, Lena F. Schimke, Gustavo Cabral-Miranda, Mario Hiroyuki Hirata, Taj Ali AKhan, Yen-Rei A. Yu, Rodrigo JS Dalmolin, Howard Amital, Aristo Vojdani, Haroldo Dutra Dias, Helder Nakaya, Hans D. Ochs, Jonathan I. Silverberg, Jason Zimmerman, Israel Zyskind, Avi Z. Rosenberg, Kai Schulze-Forster, Harald Heidecke, Rusan Catar, Guido Moll, Alexander Hackel, Kristina Kusche-Vihrog, Yehuda Shoenfeld, Gabriela Riemekasten, Reza Akbarzadeh, Alexandre H. C. Marques, Otavio Cabral-Marques |
| 2 |
[GO] |
2024―Nov―27 |
A deep learning approach predicting the activity of COVID-19 therapeutics and vaccines against emerging variants |
Robert P. Matson, Isin Y. Comba, Eli Silvert, Michiel J. M. Niesen, Karthik Murugadoss, Dhruti Patwardhan, Rohit Suratekar, Elizabeth-Grace Goel, Brittany J. Poelaert, Kanny K. Wan, Kyle R. Brimacombe, AJ Venkatakrishnan, Venky Soundararajan |
| 3 |
[GO] |
2024―Apr―17 |
SARS-CoV-2 remodels the landscape of small non-coding RNAs with infection time and symptom severity |
Julia Corell-Sierra, Joan Marquez-Molins, María-Carmen Marqués, Andrea Gabriela Hernandez-Azurdia, Roser Montagud-Martínez, María Cebriá-Mendoza, José M. Cuevas, Eliseo Albert, David Navarro, Guillermo Rodrigo, Gustavo Gómez |
| 4 |
[GO] |
2024―Apr―05 |
Metacell-based differential expression analysis identifies cell type specific temporal gene response programs in COVID-19 patient PBMCs |
Kevin O’Leary, Deyou Zheng |
| 5 |
[GO] |
2023―Apr―14 |
A quantitative systems pharmacology model of the pathophysiology and treatment of COVID-19 predicts optimal timing of pharmacological interventions |
Rohit Rao, Cynthia J. Musante, Richard Allen |
| 6 |
[GO] |
2022―Oct―10 |
Old drugs, new tricks: leveraging known compounds to disrupt coronavirus-induced cytokine storm |
Spencer Richman, Cole Lyman, Anastasia Nesterova, Anton Yuryev, Matthew Morris, Hongbao Cao, Chris Cheadle, Gary Skuse, Gordon Broderick |
| 7 |
[GO] |
2021―May―24 |
Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection |
Marisol Salgado-Albarrán, Erick I. Navarro-Delgado, Aylin Del Moral-Morales, Nicolas Alcaraz, Jan Baumbach, Rodrigo González-Barrios, Ernesto Soto-Reyes |
|
